Trademark applications and grants for Glenmark Pharmaceuticals L T D. Glenmark Pharmaceuticals L T D has 11 trademark applications. The latest application filed is for "IGI"
Patent Application | Date |
---|---|
METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF 20220257878 - 17/651044 BERRY; Julianne ;   et al. | 2022-08-18 |
CONTAINER SYSTEM AND PHARMACEUTICAL FOAM COMPOSITION COMPRISING BETAMETHASONE 20210196631 - 17/250714 Dhuppad; Ulhas ;   et al. | 2021-07-01 |
TOPICAL PHARMACEUTICAL COMPOSITION OF ADAPALENE AND MINOCYCLINE 20200345671 - 16/753729 Dhuppad; Ulhas R. ;   et al. | 2020-11-05 |
Dry Powder Inhaler 20190275269 - 16/420903 DHUPPAD; Ulhas ;   et al. | 2019-09-12 |
PROCESS FOR THE PREPARATION OF TAVABOROLE 20190023724 - 16/070002 Kuduva; Srinivasan Subramanian ;   et al. | 2019-01-24 |
NCAGE Code | 0357Y | GLENMARK PHARMACEUTICALS LIMITED |
NCAGE Code | SSP32 | GLENMARK PHARMACEUTICALS LIMITED |
CAGE Code | SSP32 | GLENMARK PHARMACEUTICALS LIMITED |
CAGE Code | 0357Y | GLENMARK PHARMACEUTICALS LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.